1. Home

Vaccines, Blood, & Biologics

Topic Paragraphs
woman biotechnologist using microscope

Vaccines, Blood, & Biologics

Center for Biologics Evaluation and Research (CBER) is the FDA center responsible for regulating biological products for human use, ensuring their safety, effectiveness, and availability. CBER also educates the public to promote the safe and appropriate use of these products.

Spotlight

News & Events
CBER Product Approval Information
CBER Rare Disease Program
Safety & Availability (Biologics)

Vaccines, Blood, & Biologics

What's New for CBER provides regularly updated news and activities from the Center for Biologics Evaluation and Research (CBER). Quickly find the latest information on biologic approvals, regulations, safety, research, and guidance-all in one place.

Biologic Products

Allergenics
Blood and Blood Products
Cellular & Gene Therapy Products
Fecal & Microbiota Products
Tissue & Tissue Products
Vaccines
Xenotransplantation

Regulatory Oversight

Vaccines, Blood, and Biologics Resources

CBER-Regulated Products: Shortages and Discontinuations
Coronavirus (COVID-19) | CBER-Regulated Biologics CBER
International Activities
Resources for You
Support for Clinical Trials Advancing Rare disease Therapeutics (START) Pilot P…
Back to Top